MXCT.US MaxCyte Inc

Healthcare Health Care Equipment & Supplies USA Stocks
1.19 USD
Close of Nov 15, 2026
0.6434 1.81
Market cap
USD 123M
P/E
-
P/B
0.81x
ROE
-16.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is MXCT.US undervalued?

Graham number

The Graham number of MaxCyte Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MaxCyte Inc fundamental analysis

No fundamental analysis for MaxCyte Inc yet.

MaxCyte Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MaxCyte Inc

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in t…

Full company profile